DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Verastem Oncology Expects Its R&D and SG&A Expenses For FY20 To Be In The Range Of $70M - $85M

Benzinga · 03/11/2020 20:13